HCM
CSII

Highbridge Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Highbridge Capital Management’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-17,100
Closed -$271K – 1898
2015
Q3 		$271K Buy
+17,100
New +$431K ﹤0.01% 1272

Other funds holding CSII

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Highbridge Capital Management's CSII Position: Q2 2017 in Review

Highbridge Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2017, closing a stake of 8,989 shares — an estimated $254K sold.

Highbridge Capital Management first reported a position in CSII in Q3 2015 and held it in 2 quarters. The position peaked at $309K in Q3 2015. 157 funds tracked by Wall St. Rank hold CSII as of Q2 2017.

  • Highbridge Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q2 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 8,989 Cardiovascular Systems, Inc. shares in Q2 2017, an estimated $254K.
  • Highbridge Capital Management first reported a position in Cardiovascular Systems, Inc. in Q3 2015 and held it in 2 quarters.
  • Highbridge Capital Management's Cardiovascular Systems, Inc. position peaked at $309K in Q3 2015.
  • 157 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2017.

Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.